Patents by Inventor Andrew Rhinehart
Andrew Rhinehart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11908561Abstract: A method includes obtaining prescribing drug information and published guidelines for each of a plurality of ADMs available for managing glucose levels, and receiving patient information associated with a patient. The method also includes ordering total demerit values from lowest to highest, selecting a predetermined number of recommended ADMs associated with the lowest total demerit values, and determining a recommended dosage for each recommended ADM. The method also includes transmitting a therapy regimen to a patient device associated with the patient. The therapy regimen includes the recommended ADMs and the recommended dosage for each recommended ADM.Type: GrantFiled: July 13, 2023Date of Patent: February 20, 2024Assignee: Aseko, Inc.Inventors: Robert C. Booth, Andrew Rhinehart, Harry Hebblewhite
-
Publication number: 20240029853Abstract: A method includes obtaining blood glucose measurements and blood glucose times of a patient from a blood glucose meter and executing a patient management program configured to display on a screen a graphical user interface having a trend window of the blood glucose measurements on the time line. The patient management program is configured to receive, in the trend window magnifying inputs for a magnification window superimposed on a segment of the timeline to specify a date range for a magnified window. The patient management program is further configured to display the magnified window including the blood glucose measurements of the patient from the specified date range and display a first information window including quantitative information associated with the blood glucose measurements from the specified date range.Type: ApplicationFiled: June 26, 2023Publication date: January 25, 2024Applicant: Aseko, Inc.Inventors: Robert C. Booth, Robert Salitsky, Andrew Rhinehart
-
Publication number: 20230360759Abstract: A method includes obtaining prescribing drug information and published guidelines for each of a plurality of ADMs available for managing glucose levels, and receiving patient information associated with a patient. The method also includes ordering total demerit values from lowest to highest, selecting a predetermined number of recommended ADMs associated with the lowest total demerit values, and determining a recommended dosage for each recommended ADM. The method also includes transmitting a therapy regimen to a patient device associated with the patient. The therapy regimen includes the recommended ADMs and the recommended dosage for each recommended ADM.Type: ApplicationFiled: July 13, 2023Publication date: November 9, 2023Applicant: Aseko, Inc.Inventors: Robert C. Booth, Andrew Rhinehart, Harry Hebblewhite
-
Patent number: 11728022Abstract: A method includes obtaining prescribing drug information and published guidelines for each of a plurality of ADMs available for managing glucose levels, and receiving patient information associated with a patient. The method also includes ordering total demerit values from lowest to highest, selecting a predetermined number of recommended ADMs associated with the lowest total demerit values, and determining a recommended dosage for each recommended ADM. The method also includes transmitting a therapy regimen to a patient device associated with the patient. The therapy regimen includes the recommended ADMs and the recommended dosage for each recommended ADM.Type: GrantFiled: December 27, 2022Date of Patent: August 15, 2023Assignee: Aseko, Inc.Inventors: Robert C. Booth, Andrew Rhinehart, Harry Hebblewhite
-
Publication number: 20230139172Abstract: A method includes obtaining prescribing drug information and published guidelines for each of a plurality of ADMs available for managing glucose levels, and receiving patient information associated with a patient. The method also includes ordering total demerit values from lowest to highest, selecting a predetermined number of recommended ADMs associated with the lowest total demerit values, and determining a recommended dosage for each recommended ADM. The method also includes transmitting a therapy regimen to a patient device associated with the patient. The therapy regimen includes the recommended ADMs and the recommended dosage for each recommended ADM.Type: ApplicationFiled: December 27, 2022Publication date: May 4, 2023Applicant: Aseko, Inc.Inventors: Robert C Booth, Andrew Rhinehart, Harry Hebblewhite
-
Patent number: 11568974Abstract: A method includes obtaining prescribing drug information and published guidelines for each of a plurality of ADMs available for managing glucose levels, and receiving patient information associated with a patient. The method also includes ordering total demerit values from lowest to highest, selecting a predetermined number of recommended ADMs associated with the lowest total demerit values, and determining a recommended dosage for each recommended ADM. The method also includes transmitting a therapy regimen to a patient device associated with the patient. The therapy regimen includes the recommended ADMs and the recommended dosage for each recommended ADM.Type: GrantFiled: December 17, 2018Date of Patent: January 31, 2023Assignee: Aseko, Inc.Inventors: Robert C. Booth, Andrew Rhinehart, Harry Hebblewhite
-
Patent number: 11062798Abstract: A method includes obtaining blood glucose measurements and blood glucose times of a patient from a blood glucose meter and executing a patient management program configured to display on a screen a graphical user interface having a trend window of the blood glucose measurements on the time line. The patient management program is configured to receive, in the trend window magnifying inputs for a magnification window superimposed on a segment of the timeline to specify a date range for a magnified window. The patient management program is further configured to display the magnified window including the blood glucose measurements of the patient from the specified date range and display a first information window including quantitative information associated with the blood glucose measurements from the specified date range.Type: GrantFiled: May 31, 2017Date of Patent: July 13, 2021Assignee: Aseko, Inc.Inventors: Robert C. Booth, Robert Salitsky, Andrew Rhinehart
-
Patent number: 10957438Abstract: A method includes obtaining blood glucose measurements and blood glucose times of a patient from a blood glucose meter and executing a patient management program configured to display on a screen a graphical user interface having a trend window of the blood glucose measurements on the time line. The patient management program is configured to receive, in the trend window magnifying inputs for a magnification window superimposed on a segment of the timeline to specify a date range for a magnified window. The patient management program is further configured to display the magnified window including the blood glucose measurements of the patient from the specified date range and display a first information window including quantitative information associated with the blood glucose measurements from the specified date range.Type: GrantFiled: September 6, 2018Date of Patent: March 23, 2021Assignee: Aseko, Inc.Inventors: Robert C. Booth, Robert Salitsky, Andrew Rhinehart
-
Publication number: 20190198146Abstract: A method includes obtaining prescribing drug information and published guidelines for each of a plurality of ADMs available for managing glucose levels, and receiving patient information associated with a patient. The method also includes ordering total demerit values from lowest to highest, selecting a predetermined number of recommended ADMs associated with the lowest total demerit values, and determining a recommended dosage for each recommended ADM. The method also includes transmitting a therapy regimen to a patient device associated with the patient. The therapy regimen includes the recommended ADMs and the recommended dosage for each recommended ADM.Type: ApplicationFiled: December 17, 2018Publication date: June 27, 2019Applicant: Aseko, Inc.Inventors: Robert C. Booth, Andrew Rhinehart, Harry Hebblewhite
-
Publication number: 20190074078Abstract: A method includes obtaining blood glucose measurements and blood glucose times of a patient from a blood glucose meter and executing a patient management program configured to display on a screen a graphical user interface having a trend window of the blood glucose measurements on the time line. The patient management program is configured to receive, in the trend window magnifying inputs for a magnification window superimposed on a segment of the timeline to specify a date range for a magnified window. The patient management program is further configured to display the magnified window including the blood glucose measurements of the patient from the specified date range and display a first information window including quantitative information associated with the blood glucose measurements from the specified date range.Type: ApplicationFiled: September 6, 2018Publication date: March 7, 2019Applicant: Aseko, Inc.Inventors: Robert C Booth, Robert Salitsky, Andrew Rhinehart
-
Publication number: 20170351842Abstract: A method includes obtaining blood glucose measurements and blood glucose times of a patient from a blood glucose meter and executing a patient management program configured to display on a screen a graphical user interface having a trend window of the blood glucose measurements on the time line. The patient management program is configured to receive, in the trend window magnifying inputs for a magnification window superimposed on a segment of the timeline to specify a date range for a magnified window. The patient management program is further configured to display the magnified window including the blood glucose measurements of the patient from the specified date range and display a first information window including quantitative information associated with the blood glucose measurements from the specified date range.Type: ApplicationFiled: May 31, 2017Publication date: December 7, 2017Applicant: Aseko, Inc.Inventors: Robert C. Booth, Robert Salitsky, Andrew Rhinehart